Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Implications for Striatal-Enriched Protein Tyrosine Phosphatase (STEP) in Neuropsychiatric Disorders
Susan Goebel-Goody, Matthew L. Baum, Constantinos D. Paspalas, et al.
Pharmacological Reviews (2011) Vol. 64, Iss. 1, pp. 65-87
Open Access | Times Cited: 152

Showing 1-25 of 152 citing articles:

The Pathophysiology of Fragile X (and What It Teaches Us about Synapses)
Asha Bhakar, Gül Dölen, Mark F. Bear
Annual Review of Neuroscience (2012) Vol. 35, Iss. 1, pp. 417-443
Open Access | Times Cited: 364
Protein tyrosine phosphatases as potential therapeutic targets
Rong Jun He, Zhi Yu, Ruo Yu Zhang, et al.
Acta Pharmacologica Sinica (2014) Vol. 35, Iss. 10, pp. 1227-1246
Open Access | Times Cited: 289
Fragile X mental retardation protein and synaptic plasticity
Michael S. Sidorov, Benjamin D. Auerbach, Mark F. Bear
Molecular Brain (2013) Vol. 6, Iss. 1
Open Access | Times Cited: 221
Stress Modulation of Opposing Circuits in the Bed Nucleus of the Stria Terminalis
Sarah Daniel, Donald G. Rainnie
Neuropsychopharmacology (2015) Vol. 41, Iss. 1, pp. 103-125
Open Access | Times Cited: 207
Molecular mechanisms underlying alcohol-drinking behaviours
Dorit Ron, Segev Barak
Nature reviews. Neuroscience (2016) Vol. 17, Iss. 9, pp. 576-591
Open Access | Times Cited: 169
The Role of the Phosphorus Atom in Drug Design
Juan B. Rodríguez, Carola Gallo‐Rodriguez
ChemMedChem (2018) Vol. 14, Iss. 2, pp. 190-216
Open Access | Times Cited: 167
Protein tyrosine phosphatases in health and disease
Wiljan Hendriks, Ari Elson, Sheila Harroch, et al.
FEBS Journal (2012) Vol. 280, Iss. 2, pp. 708-730
Closed Access | Times Cited: 151
Protein Tyrosine Phosphatases: Structure, Function, and Implication in Human Disease
Lutz Tautz, David Critton, Stefan Grotegut
Methods in molecular biology (2013), pp. 179-221
Open Access | Times Cited: 138
MAGUKs: multifaceted synaptic organizers
Sehoon Won, Jon M Levy, Roger A. Nicoll, et al.
Current Opinion in Neurobiology (2017) Vol. 43, pp. 94-101
Open Access | Times Cited: 137
Inhibitor of the Tyrosine Phosphatase STEP Reverses Cognitive Deficits in a Mouse Model of Alzheimer's Disease
Jian Xu, Manavi Chatterjee, Tyler D. Baguley, et al.
PLoS Biology (2014) Vol. 12, Iss. 8, pp. e1001923-e1001923
Open Access | Times Cited: 136
Calpains and neuronal damage in the ischemic brain: The swiss knife in synaptic injury
Michele Curcio, Ivan L. Salazar, Miranda Mele, et al.
Progress in Neurobiology (2016) Vol. 143, pp. 1-35
Closed Access | Times Cited: 87
Restraint stress effects on glutamate signaling protein levels in the rats’ frontal cortex: Does β1 adrenoceptor activity matter?
Agnieszka Zelek-Molik, A Gàdek-Michalska, Michał Wilczkowski, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 1
Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model
Susan Goebel-Goody, E. D. Wilson‐Wallis, Sam Royston, et al.
Genes Brain & Behavior (2012) Vol. 11, Iss. 5, pp. 586-600
Open Access | Times Cited: 104
Protein tyrosine phosphatase variants in human hereditary disorders and disease susceptibilities
Wiljan Hendriks, Rafael Pulido
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2013) Vol. 1832, Iss. 10, pp. 1673-1696
Open Access | Times Cited: 100
Protein Phosphatases and Alzheimer's Disease
Steven P. Braithwaite, Jeffry B. Stock, Paul J. Lombroso, et al.
Progress in molecular biology and translational science (2012), pp. 343-379
Open Access | Times Cited: 100
Fragile X syndrome: From protein function to therapy
Claudia Bagni, Ben A. Oostra
American Journal of Medical Genetics Part A (2013) Vol. 161, Iss. 11, pp. 2809-2821
Open Access | Times Cited: 92
Male-specific deficits in natural reward learning in a mouse model of neurodevelopmental disorders
Nicola M. Grissom, Sarah E. McKee, Hannah Schoch, et al.
Molecular Psychiatry (2017) Vol. 23, Iss. 3, pp. 544-555
Open Access | Times Cited: 80
GABA receptor subunit distribution and FMRP–mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism
S. Hossein Fatemi, Timothy D. Folsom
Schizophrenia Research (2014) Vol. 167, Iss. 1-3, pp. 42-56
Open Access | Times Cited: 78
The Role of Ionotropic Glutamate Receptors in Childhood Neurodevelopmental Disorders: Autism Spectrum Disorders and Fragile X Syndrome
Genoveva Uzunova, Eric Hollander, Jason D. Shepherd
Current Neuropharmacology (2014) Vol. 12, Iss. 1, pp. 71-98
Open Access | Times Cited: 71
Adenosine A2A receptor as potential therapeutic target in neuropsychiatric disorders
Maria Rosaria Domenici, Antonella Ferrante, Alberto Martire, et al.
Pharmacological Research (2019) Vol. 147, pp. 104338-104338
Closed Access | Times Cited: 59
The tyrosine phosphatase STEP: implications in schizophrenia and the molecular mechanism underlying antipsychotic medications
Nikisha Carty, Jin Xu, PU Kurup, et al.
Translational Psychiatry (2012) Vol. 2, Iss. 7, pp. e137-e137
Open Access | Times Cited: 73
Post-insult valproic acid-regulated microRNAs: potential targets for cerebral ischemia.
Joshua Hunsberger, Emily Fessler, Zhifei Wang, et al.
PubMed (2012)
Closed Access | Times Cited: 70
Comparison of Genomic and Epigenomic Expression in Monozygotic Twins Discordant for Rett Syndrome
Miyake Kunio, Chunshu Yang, Yohei Minakuchi, et al.
PLoS ONE (2013) Vol. 8, Iss. 6, pp. e66729-e66729
Open Access | Times Cited: 66
Alcohol-dependent molecular adaptations of the NMDA receptor system
Nadège Morisot, Dorit Ron
Genes Brain & Behavior (2016) Vol. 16, Iss. 1, pp. 139-148
Open Access | Times Cited: 60
STEP 61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson’s disease
Pradeep Kurup, Jian Xu, Rita Alexandra Videira, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 4, pp. 1202-1207
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top